Tag: diagnostic radioisotopes market size

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Diagnostic Radioisotopes Market from 2024 to 2033?
The diagnostic radioisotopes market is set to grow from $5.06 billion in 2023 to $5.54 billion in 2024, with a CAGR of 9.6%. Factors driving this growth include advancements in radioactivity research, the introduction of technetium-99m, various clinical applications, Cold War-era nuclear research, and the rise of positron emission tomography.

The diagnostic radioisotopes market is anticipated to grow to $8.06 billion in 2028, at a CAGR of 9.8%. Factors driving this include new radioisotope production methods, expanded clinical applications, patient-centered care, and sustainability. Trends involve hybrid imaging, theranostics, molecular imaging, and safety enhancements.

Claim Your Free Sample of the Global Diagnostic Radioisotopes Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=16033&type=smp

What Key Factors Are Fueling the Growth of the Diagnostic Radioisotopes Market?
The rising burden of cancer is expected to enhance the growth of the diagnostic radioisotopes market. This burden is linked to factors such as lifestyle choices and environmental exposures. Radioisotopes are crucial in cancer management, allowing for precise diagnosis and treatment monitoring. For instance, the European Commission reported that new cancer cases rose by 2.3% from 2020 to 2022, reaching 2.74 million. Therefore, the rising burden of cancer is driving the diagnostic radioisotopes market.

What Are the Major Segments of the Diagnostic Radioisotopes Market?
1) By Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FluoroDeoxyGlucose (FDG), Rubidium-82, Other Radioisotopes
2) By Imaging Modality: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Beta Emitters
3) By Application: Oncology, Cardiology, Other Applications
4) By End User: Hospitals, Specialty Clinics, Diagnostic Centers, Academic And Research Institutes, Other End Users

What New Trends Are Transforming the Diagnostic Radioisotopes Market?
Major companies operating in the diagnostic radioisotopes market are focused on developing advanced radiopharmaceutical technologies to enhance diagnostic accuracy and broaden nuclear medicine applications. Advanced radiopharmaceutical technology involves creating innovative compounds and techniques for precise imaging and targeted therapy. For example, in March 2022, Bracco Group, an Italy-based diagnostic imaging company, established Blue Earth Therapeutics, a subsidiary aimed at advancing next-generation therapeutic radiopharmaceutical technologies. This subsidiary focuses on developing precision-targeted therapeutic radiopharmaceuticals, starting with prostate cancer, with plans to expand into additional oncology areas.

Order Now for Fast Delivery of Your Diagnostic Radioisotopes Market Report!
https://www.thebusinessresearchcompany.com/report/diagnostic-radioisotopes-global-market-report

Which Regions Are Driving Growth in the Diagnostic Radioisotopes Market?
North America was the largest region in the diagnostic radioisotopes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Diagnostic Radioisotopes Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the diagnostic radioisotopes market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Diagnostic Radioisotopes Market Include

1. Diagnostic Radioisotopes Market Executive Summary
2. Diagnostic Radioisotopes Market Segments
3. Diagnostic Radioisotopes Market Size And Template Market Growth Rate
4.  Key Diagnostic Radioisotopes Market Trends
5. Major Diagnostic Radioisotopes Market Drivers
……
25. Key Mergers And Acquisitions In The Diagnostic Radioisotopes Market
26. Top Diagnostic Radioisotopes Companies
27. Diagnostic Radioisotopes Market Opportunities And Strategies
28. Diagnostic Radioisotopes Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:
3D Diagnostic Imaging Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/3d-diagnostic-imaging-services-global-market-report

Influenza Diagnostic Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

Breast Cancer Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The diagnostic radioisotopes market has experienced substantial growth in recent years and is poised for continued expansion. Let’s explore the factors driving this growth, significant trends, and the key players in this dynamic market.

Current Market Growth

• Market Size and Growth Rate
  • The diagnostic radioisotopes market grew from $5.06 billion in 2023 to $5.54 billion in 2024, representing a compound annual growth rate (CAGR) of 9.6%.
  • The growth in the historic period was driven by the discovery of radioactivity, the introduction of technetium-99m, clinical applications and research, Cold War era and nuclear research, and the emergence of positron emission tomography.

Future Market Prospects

• Projected Market Size and Growth Rate
  • The market is expected to grow to $8.06 billion by 2028 at a CAGR of 9.8%.
  • Key factors for future growth include emerging radioisotope production methods, expanded clinical applications, patient-centered care and safety, point-of-care imaging, and environmental sustainability and green chemistry.

Read More On The Diagnostic Radioisotopes Market Report 2024 – https://www.thebusinessresearchcompany.com/report/diagnostic-radioisotopes-global-market-report

Key Market Trends

• Hybrid Imaging Techniques
  • The integration of hybrid imaging techniques enhances diagnostic accuracy by combining anatomical and functional imaging.
• Theranostics
  • The use of radioisotopes for both diagnosis and therapy is gaining traction, enabling personalized treatment plans.
• Molecular Imaging Techniques
  • Advancements in molecular imaging techniques are providing deeper insights into cellular and molecular processes.
• Use of Cyclotrons and Generators
  • The deployment of cyclotrons and generators for isotope production is improving supply chain efficiency and reducing reliance on nuclear reactors.
• Safety and Radiation Protection
  • Enhanced safety protocols and radiation protection measures are becoming standard practice in the industry.

Rising Burden of Cancer

• Impact on Market Growth
  • The rising burden of cancer is a significant driver for the diagnostic radioisotopes market.
  • Factors contributing to the increase in cancer cases include lifestyle choices, genetic predisposition, and environmental factors.
  • Radioisotopes play a crucial role in cancer management by enabling precise diagnosis, targeted treatment, and effective monitoring.
  • For example, new cancer cases in Europe increased by 2.3% from 2020 to 2022, reaching 2.74 million, and cancer deaths rose by 2.4% in the same period.

Key Market Players

• Major Companies
  • Cardinal Health Inc., Sumitomo Heavy Industries Ltd., BWX Technologies Inc., Lantheus Holdings, Curium Pharma, Clarity Pharmaceuticals, Bracco Diagnostic Inc., Ion Beam Applications S.A., Nordion Inc., Eckert & Ziegler AG, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Global Medical Solutions Ltd., Isotopia Molecular Imaging Ltd., Cyclopharm Limited, Trasis NV, Orano Med LLC, ARTMS Inc., Radiomedix Inc., Coqu RadioPharmaceuticals Corp., IsoTherapeutics Group LLC.

Technological Innovations

• Advancements in Radiopharmaceutical Technology
  • Companies are focused on developing advanced radiopharmaceutical technology to improve diagnostic accuracy and patient outcomes.
  • For instance, Bracco Group launched Blue Earth Therapeutics in March 2022 to advance precision-targeted therapeutic radiopharmaceuticals, initially targeting prostate cancer.

Strategic Acquisitions

• Telix Pharmaceuticals and ARTMS
  • In April 2024, Telix Pharmaceuticals acquired ARTMS to enhance isotope production and market position.
  • This acquisition aims to bolster Telix’s supply chain and manufacturing capabilities, meeting the rising demand for diagnostic and therapeutic isotopes.

Market Segmentation

• By Radioisotope
  • Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FluoroDeoxyGlucose (FDG), Rubidium-82, Other Radioisotopes.
• By Imaging Modality
  • Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Beta Emitters.
• By Application
  • Oncology, Cardiology, Other Applications.
• By End User
  • Hospitals, Specialty Clinics, Diagnostic Centers, Academic and Research Institutes, Other End Users.

Regional Insights

• North America and Asia-Pacific
  • North America was the largest region in the diagnostic radioisotopes market in 2023.
  • Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The diagnostic radioisotopes market is on a robust growth trajectory, driven by technological advancements, the rising burden of cancer, and strategic industry moves. As the market continues to evolve, innovations and expansions in production and application will play pivotal roles in shaping its future.

Request for A Sample Of The Global Diagnostic Radioisotopes Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=16033&type=smp